Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study

被引:0
|
作者
Li, Kexuan [1 ]
Zhao, Fuqiang [2 ]
Guo, Yuchen [3 ]
Wu, Qingbin [4 ]
Luo, Shuangling [5 ,6 ,7 ]
Zhang, Junling [8 ]
Li, Heli [9 ]
Hu, Shidong [10 ]
Wu, Bin [1 ]
Lin, Guole [1 ]
Qiu, Huizhong [1 ]
Niu, Beizhan [1 ]
Sun, Xiyu [1 ]
Xu, Lai [1 ]
Lu, Junyang [1 ]
Du, Xiaohui [10 ]
Wang, Zheng [9 ]
Wang, Xin [8 ]
Kang, Liang [5 ,6 ,7 ]
Wang, Ziqiang [4 ]
Wang, Quan [3 ]
Liu, Qian [2 ]
Xiao, Yi [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, Div Colorectal Surg, 1 Shuai Fu Yuan Rd, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp,Dept Diagnost Radiol, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[3] First Hosp Jilin Univ, Gen Surg Ctr, Dept Gastrointestinal Surg, 1 Xin Min Ave, Changchun 130021, Peoples R China
[4] Sichuan Univ, West China Hosp, Colorectal Canc Ctr, Dept Gen Surg, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[5] Sun Yat sen Univ, Affiliated Hosp 6, Dept Gen Surg Colorectal Surg, 26 Yuan Cun Er Heng Rd, Guangzhou 510655, Peoples R China
[6] Sun Yat sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Dis, 26 Yuan Cun Er Heng Rd, Guangzhou 510655, Peoples R China
[7] Sun Yat sen Univ, Affiliated Hosp 6, Biomed Innovat Ctr, 26 Yuan Cun Er Heng Rd, Guangzhou 510655, Peoples R China
[8] Peking Univ First Hosp, Dept Gastrointestinal Surg, 8 Xi Shi Ku St, Beijing 100034, Peoples R China
[9] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, 1277 Jiefang Ave, Wuhan 430022, Peoples R China
[10] Chinese Peoples Liberat Army PLA Gen Hosp, Med Ctr 1, Dept Gen Surg, 28 Fu Xing Rd, Beijing 100853, Peoples R China
基金
中国国家自然科学基金;
关键词
Colon cancer; High-risk pathological features; Adjuvant chemotherapy; PERINEURAL INVASION; PREDICTIVE FACTOR; PROGNOSTIC-FACTOR; OXALIPLATIN; FLUOROURACIL; LEUCOVORIN; OUTCOMES; THERAPY; TRIAL;
D O I
10.1186/s12885-023-11196-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to analyze the benefit of adjuvant chemotherapy in high-risk stage II colon cancer patients and the impact of high-risk factors on the prognostic effect of adjuvant chemotherapy. Methods This study is a multi-center, retrospective study, A total of 931 patients with stage II colon cancer who underwent curative surgery in 8 tertiary hospitals in China between 2016 and 2017 were enrolled in the study. Cox proportional hazard model was used to assess the risk factors of disease-free survival (DFS) and overall survival (OS) and to test the multiplicative interaction of pathological factors and adjuvant chemotherapy (ACT). The additive interaction was presented using the relative excess risk due to interaction (RERI). The Subpopulation Treatment Effect Pattern Plot (STEPP) was utilized to assess the interaction of continuous variables on the ACT effect. Results A total of 931 stage II colon cancer patients were enrolled in this study, the median age was 63 years old (interquartile range: 54-72 years) and 565 (60.7%) patients were male. Younger patients (median age, 58 years vs 65 years; P < 0.001) and patients with the following high-risk features, such as T4 tumors (30.8% vs 7.8%; P < 0.001), grade 3 lesions (36.0% vs 22.7%; P < 0.001), lymphovascular invasion (22.1% vs 6.8%; P < 0.001) and perineural invasion (19.4% vs 13.6%; P = 0.031) were more likely to receive ACT. Patients with perineural invasion showed a worse OS and marginally worse DFS (hazardous ratio [HR] 2.166, 95% confidence interval [CI] 1.282-3.660, P = 0.004; HR 1.583, 95% CI 0.985-2.545, P = 0.058, respectively). Computing the interaction on a multiplicative and additive scale revealed that there was a significant interaction between PNI and ACT in terms of DFS (HR for multiplicative interaction 0.196, p = 0.038; RERI, -1.996; 95%CI, -3.600 to -0.392) and OS (HR for multiplicative interaction 0.112, p = 0.042; RERI, -2.842; 95%CI, -4.959 to -0.725). Conclusions Perineural invasion had prognostic value, and it could also influence the effect of ACT after curative surgery. However, other high-risk features showed no implication of efficacy for ACT in our study.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study
    Kexuan Li
    Fuqiang Zhao
    Yuchen Guo
    Qingbin Wu
    Shuangling Luo
    Junling Zhang
    Heli Li
    Shidong Hu
    Bin Wu
    Guole Lin
    Huizhong Qiu
    Beizhan Niu
    Xiyu Sun
    Lai Xu
    Junyang Lu
    Xiaohui Du
    Zheng Wang
    Xin Wang
    Liang Kang
    Ziqiang Wang
    Quan Wang
    Qian Liu
    Yi Xiao
    BMC Cancer, 23 (1)
  • [2] Influence of High-Risk Pathological Factors and their Interaction on the Survival Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer: A Retrospective Study
    Zhao, Kailong
    Li, Hongzhou
    Pang, Wenwen
    Zhao, Xuanzhu
    Zhang, Baofeng
    Fen, Zhiqiang
    Jin, Leixin
    Xue, Jun
    Chu, Tianhao
    Yan, Suying
    Wang, Wanting
    Han, Qiurong
    Yao, Yao
    Zhang, Xipeng
    Su, Xiaomin
    Zhang, Chunze
    JOURNAL OF CANCER, 2024, 15 (11): : 3531 - 3538
  • [3] Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study
    Liu, Lin-Lin
    Xiang, Zuo-Lin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [4] Adjuvant chemotherapy for stage II colon cancer: the prognostic value of high-risk features
    Cheong, C.
    Suh, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] IMPACT OF ADJUVANT CHEMOTHERAPY ON SURVIVAL OF PATIENTS WITH STAGE II COLON CANCER: RETROSPECTIVE STUDY
    ElAlfy, Eman
    ElKerm, Yasser
    Zaky, Sameh
    Kandil, Alaa
    ANNALS OF ONCOLOGY, 2011, 22 : v117 - v118
  • [6] Impact of Adjuvant Chemotherapy on Survival of Patients With Stage II Colon Cancer - Retrospective Study
    ElAlfy, E.
    El Kerm, Y.
    Kandil, A.
    Zaky, S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S440 - S440
  • [7] IMPACT OF ADJUVANT CHEMOTHERAPY ON SURVIVAL OF PATIENTS WITH STAGE II COLON CANCER: RETROSPECTIVE STUDY
    El Alfy, E. S.
    Kandil, A. S.
    Zaki, S. I.
    El Kerm, Y. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 221 - 221
  • [8] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [9] Adjuvant chemotherapy improves survival in high- risk stage II colon cancer: a retrospective cohort study
    Liu, Lin-Lin
    Xiang, Zuo-Lin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [10] Survival benefit of adjuvant chemotherapy in high-risk patients with colon cancer regardless of microsatellite instability
    Bae, Sung Uk
    Lee, Jong Lyul
    Yang, Chun-Seok
    Park, Eun Jung
    Park, Soo Yeun
    Kim, Chang Woo
    Ji, Woong Bae
    Son, Gyung Mo
    Han, Yoon Dae
    Kim, So Hyun
    Kim, Min Sung
    Park, Youn Young
    Ha Lee, Kyung
    Kim, Chang Hyun
    Ha, Gi Won
    Lee, Jaeim
    Kim, Kyeong Eui
    Jeong, Woon Kyung
    Kim, Duck-Woo
    Baek, Seong Kyu
    EJSO, 2025, 51 (06):